NCT06274437 - A Study of BND-35 in Participants With Advanced Solid Tumors | Biotech Hunter

Enrollment

280

Participants

Timeline

Start Date

June 2, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

November 30, 2027

Conditions

Cancer

Interventions

DRUG

BND-35

Pharmaceutical form: Solution for infusion; Route of administration: Intravenous

DRUG

Nivolumab

Pharmaceutical form: Solution for infusion; Route of administration: Intravenous

DRUG

Cetuximab

Pharmaceutical form: Solution for infusion; Route of administration: Intravenous

Trial Locations (5)

RECRUITING

Rabin Medical Center, Petah Tikva

RECRUITING

Sheba Medical Center, Ramat Gan

RECRUITING

Hadassah University Medical Center, Jerusalem

RECRUITING

Rambam Health Care Campus, Haifa

RECRUITING

Tel Aviv Sourasky Medical Center, Tel Aviv